These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31325350)

  • 1. Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database.
    Doneddu PE; Bianchi E; Cocito D; Manganelli F; Fazio R; Filosto M; Mazzeo A; Cosentino G; Cortese A; Jann S; Clerici AM; Antonini G; Siciliano G; Luigetti M; Marfia GA; Briani C; Lauria G; Rosso T; Cavaletti G; Carpo M; Benedetti L; Beghi E; Liberatore G; Santoro L; Peci E; Tronci S; Cotti Piccinelli S; Toscano A; Piccolo L; Verrengia EP; Leonardi L; Schirinzi E; Mataluni G; Ruiz M; Dacci P; Nobile-Orazio E;
    Eur J Neurol; 2020 Jan; 27(1):136-143. PubMed ID: 31325350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antecedent infections and vaccinations in chronic inflammatory demyelinating polyneuropathy: A European collaborative study.
    Rajabally YA; Peric S; Bozovic I; Loo LK; Kalac A; Palibrk A; Basta I
    Muscle Nerve; 2021 Dec; 64(6):657-661. PubMed ID: 34263956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy.
    Doneddu PE; Cocito D; Manganelli F; Fazio R; Briani C; Filosto M; Benedetti L; Bianchi E; Jann S; Mazzeo A; Antonini G; Cosentino G; Marfia GA; Cortese A; Clerici AM; Carpo M; Schenone A; Siciliano G; Luigetti M; Lauria G; Rosso T; Cavaletti G; Beghi E; Liberatore G; Santoro L; Spina E; Peci E; Tronci S; Ruiz M; Cotti Piccinelli S; Verrengia EP; Gentile L; Leonardi L; Mataluni G; Piccolo L; Nobile-Orazio E;
    J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1092-1099. PubMed ID: 32868387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of environmental factors and physical activity on disability and quality of life in CIDP.
    Doneddu PE; Bianchi E; Cocito D; Manganelli F; Fazio R; Filosto M; Beghi E; Mazzeo A; Cosentino G; Cortese A; Jann S; Clerici AM; Antonini G; Siciliano G; Marfia GA; Briani C; Lauria G; Rosso T; Cavaletti G; Carpo M; Benedetti L; Schenone A; Liberatore G; Peci E; Spina E; Tronci S; Cotti Piccinelli S; Toscano A; Gentile L; Piccolo L; Leonardi L; Mataluni G; Ruiz M; Sabatelli M; Santoro L; Nobile-Orazio E;
    J Neurol; 2020 Sep; 267(9):2683-2691. PubMed ID: 32430573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database.
    Doneddu PE; Cocito D; Manganelli F; Fazio R; Briani C; Filosto M; Benedetti L; Mazzeo A; Marfia GA; Cortese A; Fierro B; Jann S; Beghi E; Clerici AM; Carpo M; Schenone A; Luigetti M; Lauria G; Antonini G; Rosso T; Siciliano G; Cavaletti G; Liberatore G; Santoro L; Peci E; Tronci S; Ruiz M; Cotti Piccinelli S; Toscano A; Mataluni G; Piccolo L; Cosentino G; Sabatelli M; Nobile-Orazio E;
    J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):125-132. PubMed ID: 30297520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for osteoporosis in chronic inflammatory demyelinating polyradiculoneuropathy.
    Kim SW; Choi YC; Kim SM; Shin HY
    Muscle Nerve; 2018 Sep; 58(3):407-412. PubMed ID: 29896772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and prevalence of CIDP and the association of diabetes mellitus.
    Laughlin RS; Dyck PJ; Melton LJ; Leibson C; Ransom J; Dyck PJ
    Neurology; 2009 Jul; 73(1):39-45. PubMed ID: 19564582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of chronic inflammatory neuropathies in southeast England.
    Mahdi-Rogers M; Hughes RA
    Eur J Neurol; 2014; 21(1):28-33. PubMed ID: 23679015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database.
    Liberatore G; De Lorenzo A; Giannotta C; Manganelli F; Filosto M; Cosentino G; Cocito D; Briani C; Cortese A; Fazio R; Lauria G; Clerici AM; Rosso T; Marfia GA; Antonini G; Cavaletti G; Carpo M; Doneddu PE; Spina E; Cotti Piccinelli S; Peci E; Querol L; Nobile-Orazio E
    Neurol Sci; 2022 Jun; 43(6):3939-3947. PubMed ID: 35048233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The clinical analysis of diabetic patients with chronic inflammatory demyelinating polyradiculoneuropathy].
    Sun QL; Sun AP; Fu Y; Fan DS
    Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):749-752. PubMed ID: 30293336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyneuropathies and chronic inflammatory demyelinating polyradiculoneuropathy in multiple sclerosis.
    Suanprasert N; Taylor BV; Klein CJ; Roforth MM; Karam C; Keegan BM; Dyck PJB
    Mult Scler Relat Disord; 2019 May; 30():284-290. PubMed ID: 30870805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrences, vaccinations and long-term symptoms in GBS and CIDP.
    Kuitwaard K; Bos-Eyssen ME; Blomkwist-Markens PH; van Doorn PA
    J Peripher Nerv Syst; 2009 Dec; 14(4):310-5. PubMed ID: 20021573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy.
    Bril V; Blanchette CM; Noone JM; Runken MC; Gelinas D; Russell JW
    J Diabetes Complications; 2016; 30(7):1401-7. PubMed ID: 27389526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of chronic inflammatory demyelinating polyradiculoneuropathy in The Netherlands.
    Broers MC; de Wilde M; Lingsma HF; van der Lei J; Verhamme KMC; Jacobs BC
    J Peripher Nerv Syst; 2022 Sep; 27(3):182-188. PubMed ID: 35567759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of chronic inflammatory demyelinating polyneuropathy in the South-Eastern area of Santiago, Chile.
    Cea G; Idiáquez JF; Salinas R; Matamala JM; Villagra R; Stuardo A
    J Clin Neurosci; 2020 Apr; 74():271-273. PubMed ID: 32067826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuropathy].
    Kanbayashi T; Sonoo M
    Brain Nerve; 2015 Nov; 67(11):1388-96. PubMed ID: 26560954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic inflammatory demyelinating polyradiculoneuropathy associated with systemic lupus erythematosus.
    Julio PR; Cortês MMM; Costallat LTL; Gaino JZ; França MC; Appenzeller S
    Semin Arthritis Rheum; 2021 Feb; 51(1):158-165. PubMed ID: 33383292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between acute-onset chronic inflammatory demyelinating polyneuropathy and acute inflammatory demyelinating polyneuropathy in adult patients.
    Alessandro L; Pastor Rueda JM; Wilken M; Querol L; Marrodán M; Acosta JN; Rivero A; Barroso F; Farez MF
    J Peripher Nerv Syst; 2018 Sep; 23(3):154-158. PubMed ID: 29603827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autonomic nervous system involvement in chronic inflammatory demyelinating polyradiculoneuropathy: a literature review.
    Rzepiński Ł; Doneddu PE; Cutellè C; Zawadka-Kunikowska M; Nobile-Orazio E
    Neurol Sci; 2023 Sep; 44(9):3071-3082. PubMed ID: 37083958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy.
    Chiò A; Cocito D; Bottacchi E; Buffa C; Leone M; Plano F; Mutani R; Calvo A;
    J Neurol Neurosurg Psychiatry; 2007 Dec; 78(12):1349-53. PubMed ID: 17494979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.